Integrated Revenue Controls and Government Compliance Suite Medispend’s iContracts Revenue Management Suite (RMS) is an advanced, enterprise-class platform engineered to manage the entire contract-to-cash lifecycle for pharmaceutical manufacturers. Purpose-built for scalability, compliance, and agility, RMS serves as the central nervous system for your revenue operations—empowering you to proactively mitigate revenue leakage, streamline chargebacks and rebates, manage government pricing, and enhance forecasting accuracy, all while minimizing compliance risk in today’s increasingly complex regulatory landscape. Our solution unifies every aspect of revenue management into a seamlessly integrated suite—enabling pharmaceutical companies to scale with confidence, safeguard revenue, and stay ahead of evolving industry requirements. Whether it’s executing commercial agreements, ensuring government pricing compliance, improving Gross-to-Net forecasting, or supporting daily operations, RMS delivers the visibility, control, and expertise you need to navigate the complexities of the life sciences market with clarity and precision.
Looking for a particular iContracts employee's phone or email?
The iContracts annual revenue was $17.5 million in 2026.
Katherine Johnson is the Director of Federal Compliance Services of iContracts.
18 people are employed at iContracts.
iContracts is based in Bridgewater, New Jersey.
The NAICS codes for iContracts are [54, 54151, 5415, 51, 541, 518, 541511].
The SIC codes for iContracts are [737, 73].